ANALYSIS OF THE PPARD GENE EXPRESSION
LEVEL CHANGES IN FOOTBALL PLAYERS
IN RESPONSE TO THE TRAINING CYCLE
Domańska-Senderowska D, Snochowska A, Szmigielska P, Jastrzębski Z, Jegier A,
Kiszałkiewicz J, Dróbka K, Jastrzębska J, Pastuszak-Lewandoska D, Cięszczyk P,
Maciejewska-Skrendo A, Zmijewski P, Brzeziańska-Lasota E
*Corresponding Author: Piotr Zmijewski, Ph.D., Faculty of Medicine, University of Information Technology and Management
in Rzeszow, Rzeszow, Poland. Tel: +48-22-384-08-12. Fax: +48-22-835-09-77. E-mail: zmijewski@op.pl
page: 19
|
|
REFERENCES
1. Skogsberg J, Kannisto K, Roshani L, Gagné E, Hamsten
A, Larsson C, et al. Characterization of the human
peroxisome proliferator activated receptor δ gene and
its expression. Int J Mol Med. 2000; 6(1): 73-81.
2. N eels JG, Grimaldi PA. Physiological functions of
peroxisome proliferator-activated receptor β. Physiol
Rev. 2014; 94(3): 795-858.
3. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli
W. Differential expression of peroxisome proliferatoractivated
receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology.
1996; 137(1): 354-366.
4. Vrins CLJ, van der Velde AE, van den Oever K, Levels
JHM, Huet S, Elferink RPJO, et al. Peroxisome
proliferator-activated receptor δ activation leads to
increased transintestinal cholesterol efflux. J Lipid
Res. 2009; 50(10): 2046-2054.
5. Girroir EE, Hollingshead HE, He P. Quantitative
expression patterns of peroxisome proliferator-activated
receptor-β/δ (PPARβ/δ) protein in mice. 2009;
371(3): 456-461.
6. T umova J, Malisova L, Andel M, Trnka J. Protective
effect of unsaturated fatty acids on palmitic acid induced
toxicity in skeletal muscle cells is not mediated
by PPARδ activation. Lipids. 2015; 50(10): 955-964.
7. Briand F. Both the peroxisome proliferator-activated
receptor (PPAR) δ agonist, GW0742, and ezetimibe
promote reverse cholesterol transport in mice by
reducing intestinal re-absorption of HDL-derived
cholesterol. 2010; 2(2): 127-133.
8. van der Veen JN, Kruit JK, Havinga R, Baller JFW,
Chimini G, Lestavel S, et al. Reduced cholesterol
absorption upon PPARδ activation coincides with
decreased intestinal expression of NPC1L1. J Lipid
Res. 2005; 46(3): 526-534.
9. Muoio DM, MacLean PS, Lang DB, Li S, Houmard
JA, Way JM, et al. Fatty acid homeostasis and induction
of lipid regulatory genes in skeletal muscles of
peroxisome proliferator-activated receptor (PPAR ) α
knock-out mice. J Biol Chem. 2002; 277(29): 26089-
26097.
10. G rimaldi PA. Regulatory role of peroxisome proliferator-
activated receptor δ (PPARδ) in muscle metabolism.
A new target for metabolic syndrome treatment?
Biochimie. 2005; 87(1): 5-8.
11. E hrenborg EW, Krook A. Regulation of skeletal
muscle physiology and metabolism by peroxisome
prolif-erator-activated receptor. Pharmacol Rev.
2009; 61(3): 373-393.
12. Holst D, Luquet S, Nogueira V, Kristiansen K,
Leverve X, Grimaldi PA. Nutritional regulation and
role of peroxisome proliferator-activated receptor δ
in fatty acid catabolism in skeletal muscle. Biochim
Biophys Acta. 2003; 1633(1): 43-50.
13. Manickam R, Wahli W. Roles of peroxisome proliferator-
activated receptor β/δ in skeletal muscle
physiology. Biochimie. 2016; 136: 42-48.
14. N ahlé Z, Hsieh M, Pietka T, Coburn CT, Grimaldi
PA, Zhang MQ, et al. CD36-dependent regulation of
muscle FoxO1 and PDK4 in the PPARβ/δ-mediated
adaptation to metabolic stress. J Biol Chem. 2008;
283(21): 14317-14326.
15. Luquet S, Lopez-Soriano J, Holst D, Fredenrich
A, Melki J, Rassoulzadegan M, et al. Peroxisome
proliferator-activated receptor δ controls muscle development
and oxidative capability. FASEB J. 2003;
17(15): 2299-2301.
16. Wang YX, Zhang CL, Yu RT , Cho HK, Nelson MC,
Bayuga-Ocampo CR , et al. Regulation of muscle fiber
type and running endurance by PPARδ. PLoS Biol.
2004; 2(10): e294.
17. T anaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura
H, Ikeda Y, et al. Activation of peroxisome prolif-erator-
activated receptor δ induces fatty acid β-oxidation
in skeletal muscle and attenuates metabolic syndrome.
Proc Natl Acad Sci USA. 2003; 100(26):
15924-15929.
18. Maciejewska-Karłowska A. Polymorphic variants of
the PPAR (peroxisome proliferator-activated receptor)
genes: relevance for athletic performance. Trends
Sport Sci. 2013; 1(20): 5-15.
19. Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky
MA. Analysis of global mRNA expression in
human skeletal muscle during recovery from endurance
exercise. FASEB J. 2005;19(11):1498-1500.
20. Radzimiński Ł, Rompa P, Dargiewicz R, Ignatiuk W,
Jastrzębski Z. An application of incremental running
test results to train professional soccer players. An
Application of Incremental Running Test Results to
Train Professional Soccer Players. Baltic J Health
Phys Act. 2010; 2(1): 67-74 (http://bjhpa.journalstube.
com/view/abstract/ id/10444).
21. Desvergne B, Michalik L, Wahli W. Transcriptional
regulation of metabolism. Physiol Rev. 2006; 86(2):
465-514.
22. Yessoufou A, Wahli W. Multifaceted roles of peroxisome
proliferator-activated receptors (PPARs) at the
cellular and whole organism levels. Swiss Med Wkly.
2010; 140: w13071.
23. E gan B, Zierath JR. Exercise metabolism and the
molecular regulation of skeletal muscle adaptation.
Cell Metab. 2013; 17(2): 162-184.
24. Hawley JA, Hargreaves M, Joyner MJ, Zierath JR.
Integrative biology of exercise. Cell. 2014; 159(4):
738-749. 25. E gan B, Hawley JA, Zierath JR. SnapShot: Exercise
metabolism. Cell Metab. 2016; 24(2): 342-342.e1.
doi: 10.1016/j.cmet.2016.07.013.
26. Wahli W, Michalik L. PPARs at the crossroads of
lipid signaling and inflammation. Trends Endocrinol
Metab. 2012; 23(7): 351-363.
27. C hawla A, Repa JJ, Evans RM, Mangelsdorf DJ.
Nuclear receptors and lipid physiology: Opening the
X-files. Science. 2001; 294(5548): 1866-1870.
28. Perry CGR, Lally J, Holloway GP, Heigenhauser GJF,
Bonen A, Spriet LL. Repeated transient mRNA bursts
precede increases in transcriptional and mitochondrial
proteins during training in human skeletal muscle. J
Physiol. 2010; 588(23): 4795-4810.
29. R ussell AP, Hesselink MK, Lo SK, Schrauwen P.
Regulation of metabolic transcriptional co-activators
and transcription factors with acute exercise. FASEB
J. 2005; 19(8): 986-988.
30. E rol A. Muscle-specific PPARβ/δ agonism may
provide synergistic benefits with life style modifications.
PPAR Res. 2007; 2007: 30578. doi:
10.1155/2007/30578.
31. Pérez-Schindler J, Svensson K, Vargas-Fernández E,
Santos G, Wahli W, Handschin C. The coactivator
PGC-1α regulates skeletal muscle oxidative metabolism
independently of the nuclear receptor PPARβ/δ
in sedentary mice fed a regular chow diet. Diabetologia.
2014; 57(11): 2405-2412.
32. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P,
Muscat GEO. The peroxisome proliferator-activated
receptor β/δ agonist, GW501516, regulates the expression
of genes involved in lipid catabolism and
energy uncoupling in skeletal muscle cells. Mol Endocrinol.
2003; 17(12): 2477-2493.
33. Wang YX, Lee CH, Tiep S, Yu RT , Ham J, Kang
H, et al. Peroxisome-proliferator-activated receptor
δ activates fat metabolism to prevent obesity. Cell.
2003; 113(2): 159-170.
34. Moldoveanu AI, Shephard RJ, Shek PN. The cytokine
response to physical activity and training. Sports
Med. 2001; 31(2): 115-144.
35. Baskin KK, Winders BR, Olson EN. Muscle as a “mediator”
of systemic metabolism. Cell Metab. 2015;
21(2): 237-248.
36. T rejo-Gutierrez JF, Fletcher G. Impact of exercise on
blood lipids and lipoproteins. J Clin Lipidol. 2007;
1(3): 175-181.
37. Monda KL, Ballantyne CM, North KE. Longitudinal
impact of physical activity on lipid profiles in middleaged
adults: The Atherosclerosis Risk in Communities
Study. J Lipid Res. 2009; 50(8): 1685-1691.
38. Silva RC, Diniz Mde F, Alvim S, Vidigal PG, Fedeli
LM, Barreto SM. Physical activity and lipid profile
in the ELSA-Brasil study. Arq Bras Cardiol. 2016;
107(1): 10-19.
39. A lderete TL, Gyllenhammer LE, Byrd-Williams CE,
Spruijt-Metz D, Goran MI, Davis JN. Increasing physical
activity decreases hepatic fat and metabolic risk
factors. J Exerc Physiol Online. 2013; 15(2): 40-54.
40. Schrauwen P, Westerterp KR. The role of high-fat
diets and physical activity in the regulation of body
weight. Br J Nutr. 2000; 84(4): 417-427.
41. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N,
et al. Cardiomyocyte-restricted peroxisome proliferator-
activated receptor-δ deletion perturbs myocardial
fatty acid oxidation and leads to cardiomyopathy. Nat
Med. 2004; 10(11): 1245-1250.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
